Welcome to Stem Cell and Regenerative Medicine International
SCRMI is an international biotechnology company engaged in the development of safe and effective cell-based therapies from human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs).
This image shows H1 human embryonic stem cells (hESCs) expressing green fluorescent protein. Undifferentiated stem cells such as these provide the starting point for much of our research.
A hESC-derived megakaryocyte with positive staining for von Willebrand Factor (red), CD41 (green), and DAPI (blue) is shown. Mature megakaryocytes such as this one are responsible for producing blood platelets.
This Giemsa-stained peripheral blood smear shows a granulocyte in a sea of red blood cells. Inspired by the life saving component of red blood cells, we focus on using hES and iPS cells as a resource for donorless transfusable blood.
